Telmo Graça, PhDHead of mRNA Process Development at LonzaSpeaker
Profile
Telmo is Process and Technology Lead for mRNA at Lonza and a key member of the External Innovations team within Cell and Gene Therapies. He leads mRNA process and technology programs that transition capabilities from R&D into GMP and QC, while aligning R&D, operations, innovation, and commercial stakeholders to drive governed execution. His role includes shaping strategic, research, and licensing collaborations and advising the Global Strategy Group on technology, innovation, and investment decisions. Previously, Telmo led automated mRNA manufacturing platforms at CureVac SE. He holds a Master’s in Biological Engineering and a PhD in Immunology and Infectious Diseases.
Agenda Sessions
Advancing RNA Therapeutics through Process Innovation: mRNA and LNP Technologies Shaping the Future of in vivo CAR T Therapies
, 4:45pmView Session
